Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy (Q46160227)

20 December 2017

title

Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy (English)

1 reference

20 December 2017

1 reference

Xu ZG

1

1 reference

20 December 2017

Li SL

2

1 reference

20 December 2017

Lanting L

3

1 reference

20 December 2017

Kim YS

4

1 reference

20 December 2017

Shanmugam N

5

1 reference

20 December 2017

Reddy MA

6

1 reference

20 December 2017

Natarajan R

7

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

20 December 2017

published in

Kidney International

1 reference

20 December 2017

volume

69

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

512-519

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000137

exact match

0 references

cites work

The eicosanoids and their biochemical mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Mammalian lipoxygenases: molecular structures and functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice11See Editorial by Kasinath, p. 1918

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Elevated Urinary Prostaglandin Excretion and the Effect of Indomethacin on Renal Function in Incipient Diabetic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Renal cyclooxygenase-2 in obese Zucker (fatty) rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Physiological regulation of cyclooxygenase-2 in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Cyclooxygenase-2 inhibition and renal physiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Cardiovascular hazard and non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Stable suppression of gene expression by RNAi in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Unlocking the potential of the human genome with RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated COX-2 expression in glomerular mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000137

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000137

1 reference

20 December 2017

PubMed ID

16514433

1 reference

20 December 2017